Tag: COVID-19

Association of symptoms after COVID-19 vaccination with antibody response

Editor's Note This study by investigators in the Framingham Heart Study—an ongoing, prospective cohort study evaluating cardiovascular disease risk factors—finds that systemic symptoms after COVID-19 vaccination were associated with greater antibody response than local only or no symptoms. A total of 928 of 3,200 Framingham Heart Study participants completed this…

Read More

By: Judy Mathias
November 7, 2022
Share

Effect of kidney disease on COVID-19 outcomes

Editor's Note This study from Columbia University Medical Center, New York City, which was presented November 5 at the ASN [American Society of Nephrology] Kidney Week 2022 in Orlando, examines the effect of kidney disease and other conditions on COVID-19 outcomes during four waves of the pandemic in New York…

Read More

By: Judy Mathias
November 7, 2022
Share

Partial COVID-19 vaccination tied to decreased postop mortality, infection

Editor's Note This study from the University of Maryland, Baltimore, finds that full and partial COVID-19 vaccination reduced postoperative complications. Researchers analyzed data from patients having surgery at 1,283 VA medical facilities nationwide. Of 87,073 surgical patients, 20% were fully vaccinated, 15% were partially vaccinated, and 65% were unvaccinated. Among…

Read More

By: Judy Mathias
November 3, 2022
Share

Complexity, challenges of diagnosis, management of long COVID

Editor's Note This study led by researchers at the VA Puget Sound Health Care System and University of Washington, Seattle, highlights the complexity of diagnosing long COVID and the challenges of caring for patients with this condition. Included in the analysis were 200 randomly sampled COVID-19 patients receiving care in…

Read More

By: Judy Mathias
November 3, 2022
Share

Study: 14% of adult COVID-19 patients experience long-term symptoms

Editor's Note JAMA Network published a research article on October 27 showing the long-term effects of COVID-19 on adults in the US and evaluating vaccine effectiveness for lasting symptoms, Health Leaders Media October 28 reports. The World Health Organization defines symptoms that last for at least 2 months post-infection as…

Read More

By: Bridget Brown
October 31, 2022
Share

The Joint Commission will resume certain intracycle calls

Editor's Note The Joint Commission announced on October 26 that it will resume intracycle calls for Disease-Specific Care (DSC) and Health Care Staffing Services (HCSS) certification programs, starting January 1, 2023. These calls, which were suspended in 2021 because of COVID-19, require programs to update their intracycle tabs in the…

Read More

By: Judy Mathias
October 27, 2022
Share

Variation in treatment, outcomes by race of veterans hospitalized with COVID-19

Editor's Note This study led by the University of Pittsburgh School of Medicine finds that Black veterans hospitalized with COVID-19 were less likely to be treated with evidence-based treatments than White patients. A total of 43,222 veterans (12,135 Black and 31,087 White) hospitalized with COVID-19 in 130 Veterans Affairs Medical…

Read More

By: Judy Mathias
October 26, 2022
Share

FDA: Class I recall of Jiangsu Well Biotech COVID-19 Ag Rapid Test

Editor's Note The Food and Drug Administration (FDA) on October 12 identified the recall of Jiangsu Well Biotech’s COVID-19 Ag Rapid Test Devices as Class I, the most serious. The recall was initiated because the tests were distributed to US customers without authorization, clearance, or approval from the FDA. No…

Read More

By: Judy Mathias
October 26, 2022
Share

Rise in child RSV cases may cause hospital capacity strain in the winter

Editor's Note A “sharp rise” in cases of respiratory syncytial virus (RSV) this fall is worrying staff at US hospitals, who fear what may happen to the capacity of hospitals and other healthcare facilities if RSV, influenza, and COVID-19 infections peak around the same time this winter, The Washington Post…

Read More

By: Tarsilla Moura
October 25, 2022
Share

COVID-19 vaccine hesitancy among HCWs in academic hospitals

Editor's Note This study led by researchers from Children’s Hospital of Philadelphia examines COVID-19 vaccine hesitancy among healthcare workers (HCWs) at two large academic hospitals in Philadelphia. A total of 5,929 HCWs were surveyed, including 2,253 MDs and DOs, 582 nurse practitioners (NPs), 158 physician assistants (PAs),  and 2,936 nurses.…

Read More

By: Judy Mathias
October 24, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat